TFAP2C	O
regulates	O
transcription	O
in	O
human	O
naive	O
pluripotency	O
by	O
opening	O
enhancers	O
.	O


Naive	O
and	O
primed	O
pluripotent	O
human	O
embryonic	O
stem	O
cells	O
bear	O
transcriptional	O
similarity	O
to	O
pre	O
-	O
and	O
post	O
-	O
implantation	O
epiblast	O
and	O
thus	O
constitute	O
a	O
developmental	O
model	O
for	O
understanding	O
the	O
pluripotent	O
stages	O
in	O
human	O
embryo	O
development	O
.	O


To	O
identify	O
new	O
transcription	O
factors	O
that	O
differentially	O
regulate	O
the	O
unique	O
pluripotent	O
stages	O
,	O
we	O
mapped	O
open	O
chromatin	O
using	O
ATAC	O
-	O
seq	O
and	O
found	O
enrichment	O
of	O
the	O
activator	B-TFBS
protein	I-TFBS
-	I-TFBS
2	I-TFBS
(	I-TFBS
AP2	I-TFBS
)	I-TFBS
transcription	I-TFBS
factor	I-TFBS
binding	I-TFBS
motif	E-TFBS
at	O
naive	O
-	O
specific	O
open	O
chromatin	O
.	O


We	O
determined	O
that	O
the	O
AP2	O
family	O
member	O
TFAP2C	O
is	O
upregulated	O
during	O
primed	O
to	O
naive	O
reversion	O
and	O
becomes	O
widespread	O
at	O
naive	O
-	O
specific	O
enhancers	O
.	O


TFAP2C	O
functions	O
to	O
maintain	O
pluripotency	O
and	O
repress	O
neuroectodermal	O
differentiation	O
during	O
the	O
transition	O
from	O
primed	O
to	O
naive	O
by	O
facilitating	O
the	O
opening	O
of	O
enhancers	O
proximal	O
to	O
pluripotency	O
factors	O
.	O


Additionally	O
,	O
we	O
identify	O
a	O
previously	O
undiscovered	O
naive	O
-	O
specific	O
POU5F1	O
(	O
OCT4	O
)	O
enhancer	O
enriched	O
for	O
TFAP2C	O
binding	O
.	O


Taken	O
together	O
,	O
TFAP2C	O
establishes	O
and	O
maintains	O
naive	O
human	O
pluripotency	O
and	O
regulates	O
OCT4	O
expression	O
by	O
mechanisms	O
that	O
are	O
distinct	O
from	O
mouse	O
.	O
